CUFinder

Richard Barohn

Richard Barohn

University of Missouri

H-index: 103

North America-United States

Contact Richard Barohn

About Richard Barohn

Richard Barohn, With an exceptional h-index of 103 and a recent h-index of 62 (since 2020), a distinguished researcher at University of Missouri, specializes in the field of neurology.

His recent articles reflect a diverse array of research interests and contributions to the field:

NEO1/NEO-EXT Studies: Long-term Muscle Quantitative Magnetic Resonance Imaging and Functional Efficacy in Adults With Late-onset Pompe Disease (LOPD) on Avalglucosidase Alfa …

Safety and tolerability of phenylbutyrate in inclusion body myositis

Laboratory testing in peripheral nerve disorders

Pattern Recognition of Neuropathy and Neuronopathy: 7 Questions/11 Patterns

Opening Comments for Vol. 5 Issue 1

Longitudinal course of neurofilament light chain levels in amyotrophic lateral sclerosis—insights from a completed randomized controlled trial with rasagiline

Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial

Database Evaluation for Muscle and Nerve Diseases-DEMAND: An academic neuromuscular coding system

Richard Barohn Information

University

Position

Prof of neurology

Citations(all)

37788

Citations(since 2020)

15231

Cited By

28864

hIndex(all)

103

hIndex(since 2020)

62

i10Index(all)

300

i10Index(since 2020)

209

Email

University Profile Page

Google Scholar

Richard Barohn Skills & Research Interests

neurology

Top articles of Richard Barohn

NEO1/NEO-EXT Studies: Long-term Muscle Quantitative Magnetic Resonance Imaging and Functional Efficacy in Adults With Late-onset Pompe Disease (LOPD) on Avalglucosidase Alfa …

2024/4/14

Mazen Dimachkie
Mazen Dimachkie

H-Index: 34

Richard Barohn
Richard Barohn

H-Index: 57

Peter Young
Peter Young

H-Index: 2

Safety and tolerability of phenylbutyrate in inclusion body myositis

RRNMF Neuromuscular Journal

2024/3/1

Heather Wilkins
Heather Wilkins

H-Index: 22

Mazen Dimachkie
Mazen Dimachkie

H-Index: 34

Richard Barohn
Richard Barohn

H-Index: 57

Laboratory testing in peripheral nerve disorders

RRNMF Neuromuscular Journal

2024/3/1

Richard Barohn
Richard Barohn

H-Index: 57

Jonathan Katz
Jonathan Katz

H-Index: 56

Mazen Dimachkie
Mazen Dimachkie

H-Index: 34

Pattern Recognition of Neuropathy and Neuronopathy: 7 Questions/11 Patterns

RRNMF Neuromuscular Journal

2024/3/1

Opening Comments for Vol. 5 Issue 1

RRNMF Neuromuscular Journal

2024/3/1

Longitudinal course of neurofilament light chain levels in amyotrophic lateral sclerosis—insights from a completed randomized controlled trial with rasagiline

European Journal of Neurology

2024/3

Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial

The Lancet Neurology

2023/10/1

Tahseen Mozaffar
Tahseen Mozaffar

H-Index: 33

Laura Herbelin
Laura Herbelin

H-Index: 22

Mazen Dimachkie
Mazen Dimachkie

H-Index: 34

Jeffrey Statland
Jeffrey Statland

H-Index: 28

Omar Jawdat
Omar Jawdat

H-Index: 6

Veena Mathew
Veena Mathew

H-Index: 6

Mike Papadakis
Mike Papadakis

H-Index: 31

Thomas Lloyd
Thomas Lloyd

H-Index: 32

Sarah Jones
Sarah Jones

H-Index: 5

Matthew Elliott
Matthew Elliott

H-Index: 5

Pedro Machado
Pedro Machado

H-Index: 4

Database Evaluation for Muscle and Nerve Diseases-DEMAND: An academic neuromuscular coding system

RRNMF Neuromuscular Journal

2023/9/15

Saud Khan
Saud Khan

H-Index: 4

Laura Herbelin
Laura Herbelin

H-Index: 22

Introduction to the 2023 Neuromuscular Study Group

RRNMF Neuromuscular Journal

2023/9/15

MGFA Meeting Proceedings: Editor's Introduction

RRNMF Neuromuscular Journal

2023/8/29

Kevin O'Connor
Kevin O'Connor

H-Index: 1

Using a Bayesian model of the joint distribution of pain and time on medication to decide on pain medication for neuropathy

Communications in Statistics: Case Studies, Data Analysis and Applications

2023/7/3

Women's History Month Vignettes

RRNMF Neuromuscular Journal

2023/6/19

Quantitative sensory testing in a large cohort of neuropathy patients: QST in Neuropathy

RRNMF Neuromuscular Journal

2023/6/19

Salman Bhai
Salman Bhai

H-Index: 5

Laura Herbelin
Laura Herbelin

H-Index: 22

Richard Barohn
Richard Barohn

H-Index: 57

Dr. Louis Tompkins Wright: One of the early Black men in white coats

RRNMF Neuromuscular Journal

2023/6/19

Phase 2 trial in acetylcholine receptor antibody‐positive myasthenia gravis of transition from intravenous to subcutaneous immunoglobulin: The MGSCIg study

European Journal of Neurology

2023/5

Milind Phadnis
Milind Phadnis

H-Index: 12

Laura Herbelin
Laura Herbelin

H-Index: 22

Reply to Weiss

2023/4/29

Richard Barohn
Richard Barohn

H-Index: 57

A 40-week Phase 2B Randomized, Multicenter, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of Memantine in Amyotrophic Lateral Sclerosis (P8-8.011)

2023/4/25

Salman Bhai
Salman Bhai

H-Index: 5

Dan Moore
Dan Moore

H-Index: 40

Richard Barohn
Richard Barohn

H-Index: 57

Myasthenia Gravis Exacerbation after Discontinuing Mycophenolate: Was Mycophenolate Effective or Not?

2023/3/13

Ketamine treatment for amyotrophic lateral sclerosis

2023/3/2

Phase II Trial in AChR Ab+ Myasthenia Gravis of Transition from Intravenous to Subcutaneous Immunoglobulin: The MGSCIg Study.

European Journal of Neurology

2023/2/13

See List of Professors in Richard Barohn University(University of Missouri)

Co-Authors

academic-engine

Useful Links

List of top 50 universities
List of top 100 universities
List of top 500 universities
Find Professors Email
Find Universities Email
CUFinder Academic Engine